Hello, Fool! | Login | Signup | My Fool
Oct 11, 2008 12:57 AM ET | Feedback | Site Changes | Help
A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body's inflammatory response.
View Ticker Page (CRTX)
Results 1 - 7 of 7 : 1
Recs
spikenailz (< 20) Submitted: 7/26/07 10:42 AM : Start Price: $2.30 CRTX Score: -50.30
They have had huge success with their asthma meds and they have some new ones in late stages of trials. This company has no where to go but up.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
jupamc (< 20) Submitted: 6/19/07 3:30 PM : Start Price: $2.36 CRTX Score: -49.31
Expect major revenue increases starting 2H07 due to increase of effective salesforce from 20 to 240 with Dey partnership and new reformulation of zileuton (ZyFlo CR). May see some earlier rev. uptick due to co-marketing started in Q2. New formulation...
romad829 (59.13) Submitted: 8/15/07 8:47 PM : Start Price: $2.46 CRTX Score: -55.18
Will go up post fall season.
jegray88 (< 20) Submitted: 10/17/07 12:16 PM : Start Price: $2.40 CRTX Score: -49.07
Recent gov't approval for a sustained release asthma medication. Young company partnering with older more stabilized companies to work on innovations in medicine.
henncoop (87.14) Submitted: 5/16/07 1:27 PM : Start Price: $2.35 CRTX Score: -50.18
new product or reformation of current product should be approved ..so more revenue
SPECTRAMAN (51.34) Submitted: 6/06/07 5:48 PM : Start Price: $2.64 CRTX Score: -50.82
Let's see what happens.
kevinnail (< 20) Submitted: 7/26/07 9:41 AM : Start Price: $2.31 CRTX Score: -50.42
They have some awesome asthma meds on the market and other stuff in the pipeline coming on board in the near future.
Terms & Conditions
RSS Headlines
Fool UK